New medical tests can be moneymakers for small- and mid-cap companies: They save insurers the pain of paying more to treat maladies and save patients from unnecessary treatments.
http://seekingalpha.com/article/1473161-diagnostics-and-stem-cells-power-productive-portfolios-kevin-degeeter?source=feed
http://seekingalpha.com/article/1473161-diagnostics-and-stem-cells-power-productive-portfolios-kevin-degeeter?source=feed
No comments:
Post a Comment